top of page

- exposure therapy -

Approaching addiction and phobias from a neurobiological slant, and conceptualizing both as a form of hyper-learning, I base treatment on interventions that promote un-learning. The foundation of my treatment approach as it relates to panic-phobias relies on Exposure Therapy. Developed in the 1920s, Exposure Therapy (ET)  typically targets anxiety disorders, with a long track record of success in alleviating panic-phobic conditions. ET un-pairs a panic response from a feared stimuli, in a process known as desensitization.

As an example, a therapist practicing ET to treat a dog phobia might write out a treatment plan that either gradually or dramatically exposes a person to the anxiety-inducing triggers associated with dogs (videos of dogs, the sound of barking, dog odors, an actual dog). As the person confronts the anxiety activated by those triggers, he or she develops distress tolerance. That is, the person becomes less sensitive (i.e., desensitized) to the triggers and the anxiety that they activate. Through the exposure, the person learns that he or she can survive the physiological surge that is anxiety, while debunking the thoughts that predicted a crisis (e.g., a dog attack). Once the triggers are neutralized, the person can relax more around canines, his or her phobia now easier to control.

As noted in PLASTICITY, addictive behaviors prime the mesolimbic system much like phobic conditions, as it becomes increasingly sensitive to cues associated with a substances of choice. Not only will the brain fire off more forcefully in the presence of those cues to use, but it associates more & more cues to using over time. That’s what researcher label as sensitization. I use the basics of ET to help the brain desensitize from - to unlearn - the most prominent of cues, those high risk situations, people, or internal states that trigger cravings to use. Fundamentally, ET works by resetting the mesolimbic system, so that it is less reactive, less sensitive to triggers. The key to this behavioral method is context (Torregrossa, MM & Taylor, JR, 2012).

Over the last 20 years, practitioners have used an intervention known as Cue Exposure Therapy (CET) to treat addictions, with mixed results. The limited effect of CET is due, more times than not, to the lack of context-specific planning. Often, CET is used in offices, in outpatient clinics, in rehabs or on hospital floors. How often, though, do people use or drink in those environments? Hopefully never.

Learning – and therefore unlearning – is context-dependent. CET rarely demonstrates a sizeable effect because it’s not practiced in the real world, context-specific situations that those with addictive disorders routinely drink or use in (Berridge, K, 2001; Conklin CA, & Tiffany ST, 2002). My application of ET in the treatment of addictive behaviors might be described as mobile, as I plan interventions in a client’s real world – his or her home, favorite bar, or other so-called high risk situations.

​A traditional approach to relapse prevention planning encourages those in early recovery to avoid high risk situations. A safe plan, no doubt. Such passive coping, however, prevents extinction learning. Consequently, cravings are apt to survive longer and crop up more regularly compared to those who practice more proactive forms of coping with cues to use. As in the treatment of panic disorders, triggers must be confronted if their collective effect is to subside.

Some neuroscientists argue that dysregulation in the brain’s stress system is what drives addiction (Rajita, 2007; Koob, 2009), as it does panic disorders. Panic & cravings can each be conceptualized as an acute stress response, each linked to intense activation in the basal forebrain – the terminal point of the meso-limbic system. (Koob 2009, 2010, 2013; Martin-Fardon, Zorrilla, Ciccocioppo, & Weiss 2010). Also, panic & cravings share a similar ignition switch, with both experiences tied to the amygdala - the trigger point in the meso-limbic system (Feldstein-Ewing, S, et al., 2011; Rajita, 2007; Potenza, M, et al., 2011). Simply consider the shared symptoms that cravings and panic attacks manifest:

•Sweating •Rapid pulse •Agitation •Racing thoughts 

•Restless legs & pacing •Obsessiveness •Erratic breathing

​Those in the throes of a craving usually present as agitated, distressed, fidgety, if not panicky in their intense need to use. The striking similarity in symptomology between panic and cravings highlights neurobiological overlap. Hence, the intuitve use of ET to treat addictions. 

ET stabilizes the brain's stress system, which runs amok in both anxiety disorders and addictions. In both conditions, the brain becomes hyper-sensitive to stress, resulting in more frequent and intense stress reactions that require a longer recovery time. Basically, ET is thought to normalize activity in the white-hot mesolimbic system, enabling more recruitment from the advanced areas in the forebrain (Marissen, et al., 2007; Vollstadt-Klein, et al., 2011). Increased access to the forebrain promotes greater impulse control, enhanced judgment & forethought, and improved social IQ - the stuff of relationships. It's relationships, finally, that ultimately sustain recovery. My treatment strives in the short-term to manage the biological force - cravings - that perpetuate addiction and relapse, so that someone can begin the longer work of repairing relationships.

Dog's Portrait

Exposure therapy represents a short-term, intensive therapy that confronts a phobia in 4-12 sessions.

ET works to desensitize  the triggers to panic, while enhancing risk appraisal.

Over the last quarter century, ET has become more common in addiction treatment.

Five common phobias:

1. Acrophobia - fear of heights

2. Agoraphobia - fear of no escape 

3. Arachnophobia - fear of spiders

4. Aerophobia - fear of flying 

5. Trypanophobia - fear of injections

REFERENCES:

Alderman, BL, Olson, RL, Brush, CJ  and Shors, TJ. MAP training: combining meditation and aerobic exercise reduces depression and rumination while enhancing synchronized brain activity. Translational Psychiatry (2016), 6, e726

Beauregard, M. Functional neuroimaging studies of the effects of psychotherapy. Dialogues Clinical Neuroscience, 2014, Mar, 16(1), 75–81.

 

Blum, K., Femino, J., Teitelbaum, S., Giordano, J., Oscar-Berman, M., Gold, M. (2013). Molecular Neurobiology of Addiction Recovery: The 12 Steps Program and Fellowship. Springer Briefs in Neuroscience. Springer-Verlag New York. DOI 10.1007/978-1-4614-7230-8

 

Cover Jones, M. (1924). A Laboratory Study of Fear: The Case of Peter. Pedagogical Seminary, 31 (4): 308–315. 

Dempsey JP, Harris KS, Shumway ST, Kimball TG, Herrera JC, Dsauza CM, Bradshaw SD. Functional near infrared spectroscopy as a potential biological assessment of addiction recovery: preliminary findings. American Journal of Drug and Alcohol Abuse, 2015, Mar, 41(2), 119-26.

 

Feldstein Ewing SW, Chung T. Neuroimaging mechanisms of change in psychotherapy for addictive behaviors: emerging translational approaches that bridge biology and behavior. Psychology of Addictive Behaviors, 2013, Jun, 27 (2), 329-35.

 

Feldstein-Ewing, SW, Filbey, FM, et al. Proposed Model of the Neurobiological Mechanisms Underlying Psychosocial Alcohol Interventions: The Example of Motivational Interviewing. Journal of Studies on Alcohol and Drugs. 2011, Nov, 72(6), 903–916.

 

Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry. 2004, Jan, 61(1), 34-41.

 

Goldstein RZ, Craig AD, Bechara A, Garavan H, Childress AR, Paulus MP, Volkow ND. The neurocircuitry of impaired insight in drug addiction. Trends in Cognitive Sciences, 2009, Sep, 13(9), 372-80

 

Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nature Reviews Neuroscience, 2011, Oct 20, 12(11), 652-69

 

Holzschneider K & Mulert C. Neuroimaging in anxiety disorders. Dialogues Clinical Neuroscience, 2011, 13(4), 453-61.

 

Karlsson, H. How Psychotherapy Changes the Brain. August 11, 2011. http://www.psychiatrictimes.com/psychotherapy/how-psychotherapy-changes-brain

 

Koob, GF. Brain stress systems in the amygdala and addiction. Brain Research, 2009, October 13, 1293, 61–75.

Martin-Fardon R, Zorrilla EP, Ciccocioppo R, Weiss F. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction. Brain Research, 2010, Feb, vol.16, 1314, 145-61

 

Nosen, E., et al., Treatment of co-occurring PTSD-AUD: Effect of exposure-based and non-trauma psychotherapy on alcohol and trauma cue reactivity. Behaviour Research and Therapy, Oct 2014, vol. 61. 

Porto PR, Oliveira L, Mari J, Volchan E, Figueira I, Ventura P. Does cognitive behavioral therapy change the brain? A systematic review of neuroimaging in anxiety disorders. Journal of Neuropsychiatry & Clinical  Neuroscience, 2009, Spring, 21(2), 114-25.

​Potenza, MN, Sofuoglu, M, Carroll, K., and Rounsaville, BJ (2011). Neuroscience of Behavioral and Pharmacological Treatment for Addictions, Neuron, 69, Feb 24,  p. 695 

Quintero GC. Role of nucleus accumbens glutamatergic plasticity in drug addiction. Journal of Neuropsychiatric Disease and Treatment, 2013, 9, 1499-512

Thayer RE, Hutchison KE. Neuroimaging in clinical studies of craving: importance of reward and control networks. Psychology of Addictive Behaviors, 2013, Jun, 27(2), 543-6.

Torregrossa MM & Taylor JR. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction. Psychopharmacology (Berl)., 2013, Apr, 226(4), 659-72.

Vollstädt-Klein S, Loeber S, Kirsch M, Bach P, Richter A, Buhler M, von der Goltz C, Hermann D, Mann K, Kiefer F. Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial. Biological Psychiatry, 2011, 69, 1060–1066

Weirs, CE, Stelzel, C, et al., (2014). Neural Correlates of Alcohol-Approach Bias in Alcohol Addiction: the Spirit is Willing but the Flesh is Weak for Spirits, Neuropsychopharmacology, 39, p.688-697

Anchor 1
Anchor 2
Anchor 3
Anchor 4
Anchor 5
REFs ET
bottom of page